Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !
Option Care Health Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
Option Care HealthDer Gewinn des Unternehmens wird voraussichtlich um 0.6% pro Jahr sinken, während der Jahresumsatz voraussichtlich um 8.5% pro Jahr wachsen wird. Der Gewinn pro Aktie wird voraussichtlich sinken um 0.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 15.4% betragen.
Wichtige Informationen
-0.4%
Wachstumsrate der Gewinne
-0.6%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 17.1% |
| Wachstumsrate der Einnahmen | 8.6% |
| Zukünftige Eigenkapitalrendite | 15.4% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 31 May 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Option Care Health: A Deep Dive Into Its Market Dominance
May 31Option Care Health, Inc.'s (NASDAQ:OPCH) Shareholders Might Be Looking For Exit
May 23
We Ran A Stock Scan For Earnings Growth And Option Care Health (NASDAQ:OPCH) Passed With Ease
May 10Does Option Care Health (NASDAQ:OPCH) Have A Healthy Balance Sheet?
Apr 11Is Option Care Health, Inc. (NASDAQ:OPCH) Trading At A 42% Discount?
Mar 28Is It Time To Consider Buying Option Care Health, Inc. (NASDAQ:OPCH)?
Feb 12Option Care Health (NASDAQ:OPCH) Has A Pretty Healthy Balance Sheet
Jan 02There's Reason For Concern Over Option Care Health, Inc.'s (NASDAQ:OPCH) Price
Dec 19Is There An Opportunity With Option Care Health, Inc.'s (NASDAQ:OPCH) 27% Undervaluation?
Dec 06With EPS Growth And More, Option Care Health (NASDAQ:OPCH) Makes An Interesting Case
Nov 08Is It Too Late To Consider Buying Option Care Health, Inc. (NASDAQ:OPCH)?
Oct 26Does Option Care Health (NASDAQ:OPCH) Have A Healthy Balance Sheet?
Sep 13Is Option Care Health, Inc. (NASDAQ:OPCH) Trading At A 24% Discount?
Aug 30Does Option Care Health (NASDAQ:OPCH) Deserve A Spot On Your Watchlist?
Aug 10Is Option Care Health, Inc. (NASDAQ:OPCH) Potentially Undervalued?
Jul 27Here's Why Option Care Health (NASDAQ:OPCH) Can Manage Its Debt Responsibly
Jun 09An Intrinsic Calculation For Option Care Health, Inc. (NASDAQ:OPCH) Suggests It's 37% Undervalued
May 25What Is Option Care Health, Inc.'s (NASDAQ:OPCH) Share Price Doing?
Apr 24Here's Why We Think Option Care Health (NASDAQ:OPCH) Might Deserve Your Attention Today
Apr 11We Like These Underlying Return On Capital Trends At Option Care Health (NASDAQ:OPCH)
Mar 17Option Care Health (NASDAQ:OPCH) Seems To Use Debt Quite Sensibly
Mar 05Estimating The Intrinsic Value Of Option Care Health, Inc. (NASDAQ:OPCH)
Feb 21Should You Think About Buying Option Care Health, Inc. (NASDAQ:OPCH) Now?
Jan 16Should You Be Adding Option Care Health (NASDAQ:OPCH) To Your Watchlist Today?
Jan 04Some Shareholders Feeling Restless Over Option Care Health, Inc.'s (NASDAQ:OPCH) P/E Ratio
Dec 05We Think Option Care Health (NASDAQ:OPCH) Can Stay On Top Of Its Debt
Nov 22The Return Trends At Option Care Health (NASDAQ:OPCH) Look Promising
Nov 10Option Care Health, Inc.'s (NASDAQ:OPCH) Intrinsic Value Is Potentially 41% Above Its Share Price
Sep 30Is Now The Time To Put Option Care Health (NASDAQ:OPCH) On Your Watchlist?
Sep 12Option Care Health announces secondary offering of 11M shares of common stock
Aug 16Option Care Health: Trigger Heavy On This Long-Term Cash Compounder
Aug 10At US$34.49, Is Option Care Health, Inc. (NASDAQ:OPCH) Worth Looking At Closely?
Aug 07Option Care Health Q2 2022 Earnings Preview
Jul 26Are Investors Undervaluing Option Care Health, Inc. (NASDAQ:OPCH) By 35%?
Jun 30We Think Option Care Health (NASDAQ:OPCH) Can Stay On Top Of Its Debt
Jun 18Is Now The Time To Put Option Care Health (NASDAQ:OPCH) On Your Watchlist?
Jun 06Option Care Health (NASDAQ:OPCH) Is Doing The Right Things To Multiply Its Share Price
May 25Option Care Health: Top Infusion Therapy Player With Promising Growth Prospects
May 04Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 5,616 | 269 | 308 | 357 | 4 |
| 12/31/2025 | 5,175 | 234 | 270 | 316 | 8 |
| 12/31/2024 | 4,754 | 203 | 263 | 306 | 8 |
| 3/31/2024 | 4,433 | 273 | 171 | 213 | N/A |
| 12/31/2023 | 4,302 | 267 | 329 | 371 | N/A |
| 9/30/2023 | 4,205 | 257 | 324 | 364 | N/A |
| 6/30/2023 | 4,133 | 240 | 351 | 390 | N/A |
| 3/31/2023 | 4,045 | 159 | 289 | 325 | N/A |
| 12/31/2022 | 3,945 | 151 | 232 | 268 | N/A |
| 9/30/2022 | 3,845 | 178 | 258 | 289 | N/A |
| 6/30/2022 | 3,716 | 175 | 225 | 253 | N/A |
| 3/31/2022 | 3,595 | 173 | 195 | 223 | N/A |
| 12/31/2021 | 3,439 | 140 | 183 | 209 | N/A |
| 9/30/2021 | 3,316 | 82 | 143 | 169 | N/A |
| 6/30/2021 | 3,206 | 48 | 142 | 166 | N/A |
| 3/31/2021 | 3,086 | 9 | 103 | 127 | N/A |
| 12/31/2020 | 3,033 | -8 | 101 | 127 | N/A |
| 9/30/2020 | 2,949 | -42 | 97 | 125 | N/A |
| 6/30/2020 | 2,783 | -86 | 41 | 70 | N/A |
| 3/31/2020 | 2,539 | -92 | 21 | 49 | N/A |
| 12/31/2019 | 2,310 | -76 | 11 | 39 | N/A |
| 9/30/2019 | 2,095 | -57 | 10 | 29 | N/A |
| 6/30/2019 | 1,973 | -12 | 27 | 48 | N/A |
| 3/31/2019 | 1,956 | -3 | 23 | 48 | N/A |
| 12/31/2018 | 1,940 | -6 | -2 | 24 | N/A |
| 12/31/2017 | 1,782 | 4 | N/A | 38 | N/A |
| 12/31/2016 | 1,673 | 4 | N/A | 86 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: OPCHFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-0.6% pro Jahr).
Ertrag vs. Markt: OPCHFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-0.6% pro Jahr).
Hohe Wachstumserträge: OPCHFür die nächsten 3 Jahre wird mit einem Rückgang der Erträge gerechnet.
Einnahmen vs. Markt: OPCHDie Einnahmen des Unternehmens (8.5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.4% pro Jahr).
Hohe Wachstumseinnahmen: OPCHDie Einnahmen des Unternehmens (8.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: OPCHDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (15.4 %).